Calpain-mediated ataxin-3 cleavage in the molecular pathogenesis of spinocerebellar ataxia type 3 (SCA3)Jeannette Hübener‐Schmid, Huu Phuc Nguyen, Péter Breuer et al.|Human Molecular Genetics|2012Cited by 78
From Pathways to Targets: Understanding the Mechanisms behind Polyglutamine DiseaseJonasz Jeremiasz Weber, Jeannette Hübener‐Schmid, Anna Sowa et al.|BioMed Research International|2014Cited by 70
A combinatorial approach to identify calpain cleavage sites in the Machado-Joseph disease protein ataxin-3Jonasz Jeremiasz Weber, Jeannette Hübener‐Schmid, Matthias Golla et al.|Brain|2017Cited by 44
Mitochondrial Morphology, Function and Homeostasis Are Impaired by Expression of an N-terminal Calpain Cleavage Fragment of Ataxin-3Tina Harmuth, Jeannette Hübener‐Schmid, Caroline Prell-Schicker et al.|Frontiers in Molecular Neuroscience|2018Cited by 43
<i>In vivo</i> assessment of riluzole as a potential therapeutic drug for spinocerebellar ataxia type 3Jana Schmidt, Olaf Rieß, Thorsten Schmidt et al.|Journal of Neurochemistry|2016Cited by 34